1. Treatment for Triple-Negative Breast Cancer: An Umbrella Review of Meta-Analyses
   Jianyun Yin et al, 2022, International Journal of General Medicine CrossRef
2. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231
   Kanji Furuya et al, 2016, Human Cell CrossRef
3. Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis
   Weiqiang Qiao et al, 2017, PLOS ONE CrossRef
4. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis
   Weiqiang Qiao et al, 2019, European Journal of Surgical Oncology CrossRef
5. Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy
   Fouzia Guestini et al, 2019, Breast Cancer Research and Treatment CrossRef
6. Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
   Qiang Wu et al, 2019, Frontiers in Oncology CrossRef
7. Effect of antitumor treatments on triple-negative breast cancer patients
   Qiuhong Tian et al, 2017, Medicine CrossRef